medicines company
(MDCO:Consolidated Issue Listed on Nasdaq Glbl Slct Mrkt)
Earnings & Estimates Summary - MEDICINES COMPANY (MDCO)
2012 revenues at The Medicines Company totaled $558.6M USD, while annual earnings equaled $1.91 per share.
Quarterly Earnings & Estimates - MEDICINES COMPANY (MDCO)
50.00%
The Medicines Company's Quarterly Earnings
The Medicines Company reported 1st quarter 2013 earnings of $0.31 per share on 04/26/2013.
Annual Earnings & Estimates - MEDICINES COMPANY (MDCO)
The Medicines Company's Annual Earnings
The Medicines Company reported annual 2012 earnings of $1.91 per share on 02/22/2013.
Quarterly Revenues - MEDICINES COMPANY (MDCO)
The Medicines Company's Quarterly Revenues
The Medicines Company had 1st quarter 2013 revenues of $155.8M USD. This bettered the $152.6M USD consensus of the 8 analysts covering the company. This was 23.0% above the prior year's 1st quarter results.
Annual Revenues - MEDICINES COMPANY (MDCO)
The Medicines Company's Annual Revenues
The Medicines Company had revenues for the full year 2012 of $558.6M USD. This was 15.2% above the prior year's results.
| Recently Viewed | |||
| MDCO:US | $35.76 USD | 0.00 |  |
| Company | Last | Change |
| Actelion Ltd | SFr.58.80 CHF | -0.20 |
| Baxter International Inc | $72.94 USD | +1.09 |
| Eli Lilly & Co | $55.90 USD | -0.04 |
| GlaxoSmithKline PLC | 1,713 GBp | +5.00 |
| Medicure Inc | C$0.24 CAD | 0.00 |
| View Industry Companies | ||
Industry Analysis
MDCO
Industry Average
| Valuation | MDCO | Industry Range |
| Price/Earnings | 61.2x |
|
| Price/Sales | 3.3x |
|
| Price/Book | 3.2x |
|
| Price/Cash Flow | 62.4x |
|
| TEV/Sales | 2.6x |
|
Post a JobJobs
- New Jersey | Medicines CompanyPosted: May 09
- Redwood City, CA | Medicines CompanyPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact MEDICINES COMPANY, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
